MEG3 and central nervous system cancer: Among them, the expressions of MALAT1, LINC01018, and MEG3 were lower in glioma (Figure 7B–D), and the three were discovered to be the lncRNAs that possibly targeted miR‐942‐5p (Figure 7A).